Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Annals of Surgical Oncology
|
July 16, 2014
Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma
Monisha Sudarshan, Thierry Alcindor, Steven Ades, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
July 14, 2023
Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma
Nabeel Ahmed, James Tankel, Jamil Asselah, et al.
JCO Precision Oncology
|
July 6, 2026
Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency
Thierry Alcindor, David J Papke, Vinayak Venkataraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
Gregory M Cote, Candace L Haddox, Edwin Choy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 24, 2019
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, et al.
Pancreas
|
May 16, 2019
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, et al.
The American Journal of Surgical Pathology
|
June 12, 2026
Clinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified Sarcomas
Igor Odintsov, Jonathan A Nowak, Esther Baranov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
George D Demetri, Patrick Schöffski, Giovanni Grignani, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 4, 2024
Survival in esophageal cancer with nonregional lymphadenopathy: a propensity score-matched analysis
James Tankel, Rawan Sakalla, Neyla Boukhili, et al.
International Journal of Molecular Sciences
|
January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy
Karen Gambaro, Maud Marques, Suzan McNamara, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Annals of Surgical Oncology
|
July 16, 2014
Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma
Monisha Sudarshan, Thierry Alcindor, Steven Ades, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
July 14, 2023
Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma
Nabeel Ahmed, James Tankel, Jamil Asselah, et al.
JCO Precision Oncology
|
July 6, 2026
Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency
Thierry Alcindor, David J Papke, Vinayak Venkataraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
Gregory M Cote, Candace L Haddox, Edwin Choy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 24, 2019
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, et al.
Pancreas
|
May 16, 2019
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, et al.
The American Journal of Surgical Pathology
|
June 12, 2026
Clinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified Sarcomas
Igor Odintsov, Jonathan A Nowak, Esther Baranov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
George D Demetri, Patrick Schöffski, Giovanni Grignani, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 4, 2024
Survival in esophageal cancer with nonregional lymphadenopathy: a propensity score-matched analysis
James Tankel, Rawan Sakalla, Neyla Boukhili, et al.
International Journal of Molecular Sciences
|
January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy
Karen Gambaro, Maud Marques, Suzan McNamara, et al.
Page
of 7